inforMED
InjuryLSL

APTIMA COMBO 2 ASSAY

Received Jun 3, 2026 · Event occurred May 21, 2026

Report 2024800-2026-00027 · MDR key 25384549

Device

Generic name

Dna-reagents, Neisseria

Manufacturer

Hologic, Inc.

Catalog number

ASY-13823

Lot number

928004

Product problems

  • Imprecise or Erratic Results

Patient

NA · Unknown

  • No Clinical Signs, Symptoms or Conditions

Narrative

Additional Manufacturer Narrative

HOLOGIC REVIEWED THE PANTHER LOG FILES AND WORKLISTS AND NOTED THERE WERE NO INDICATIONS OF HARDWARE OR REAGENT PREPARATION ISSUES THAT AFFECTED RESULTS. THE DISCREPANT RESULT APPEARED TO BE SAMPLE RELATED, POSSIBLY DUE TO LOW TARGET CONCENTRATION OR SAMPLE MISHANDLING. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.

Description of Event or Problem

ON (B)(6) 2026, CUSTOMER REPORTED TO HOLOGIC INCONSISTENT SAMPLE RESULTS WHILE PERFORMING VALIDATION TESTING WHILE USING THE APTIMA COMBO 2 (AC2) ASSAY ON THEIR PANTHER FUSION PLUS INSTRUMENTS. CUSTOMER CONFIRMED THAT THE INITIAL TEST RESULTS WERE REPORTED OUT. CUSTOMER PROVIDED LOGS. ON (B)(6) 2026, SAMPLE ID (SID) (B)(6) WAS INITIALLY TESTED ON CT/GC WORKLIST (B)(4) (ML 926168) ON PANTHER INSTRUMENT (SN (B)(6) AND RESULTED CT POSITIVE/GC NEGATIVE. ON (B)(6) 2026, CUSTOMER RETESTED THE SAME SAMPLE (SID) (B)(6) ON CT/GC WORKLIST (B)(4) (ML 928004) ON A DIFFERENT PANTHER INSTRUMENT (SN (B)(6), AND THE VALIDATION TEST RESULTED CT POSITIVE/GC POSITIVE. CUSTOMER DID NOT PROVIDE ANY INFORMATION ON THE PATIENT OR PATIENT TREATMENT. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE. INSTRUMENT WAS OPERATIONAL, AND NO FURTHER ISSUES WERE REPORTED.